Company Valuation: ABL Diagnostics

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 2.96 3.988 29 156.3 39.64 48.34
Change - 34.75% 627.14% 439.03% -74.64% 21.95%
Enterprise Value (EV) 1 0.6006 1.286 30.64 157.5 41.66 49.27
Change - 114.05% 2,283.25% 414.19% -73.55% 18.27%
P/E -33.1x 15.5x 206x 2,876x 123x 50x
PBR 1.25x 1.52x 34.5x 23.1x 5.29x 6.32x
PEG - -0x -4.5x -30.2x 0x 0x
Capitalization / Revenue - 221,548,833,333x 3,097,618x 25,256,446x 6,753,666x 6,068,760x
EV / Revenue - - - - - -
EV / EBITDA - - - - - -
EV / EBIT -6.59x -12.5x 517x -240x -85x 155x
EV / FCF - - - - - -
FCF Yield - - - - - -
Dividend per Share 2 - - - - 0.05 0.11
Rate of return - - - - 2.03% 3.67%
EPS 2 -0.0445 0.1285 0.07 0.003373 0.02 0.06
Distribution rate - - - - 250% 183%
Net sales - 0.000018 9.361 6.189 5.869 7.966
EBITDA - - 0.62 0.005134 0.2459 0.4283
EBIT 1 -0.0912 -0.1026 0.0593 -0.6571 -0.4904 0.3171
Net income 1 -0.0893 0.2579 1.106 0.0544 0.2852 0.9867
Net Debt 1 -2.359 -2.702 1.643 1.244 2.024 0.9326
Reference price 2 1.475 1.988 14.452 9.700 2.460 3.000
Nbr of stocks (in thousands) 2,006 2,006 2,006 16,114 16,114 16,114
Announcement Date 4/23/21 5/20/22 8/1/23 7/31/24 5/6/25 5/7/26
1EUR in Million2EUR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 43.95M
30.71x4.19x16.29x2.4% 187B
19.69x3.43x12.07x3.42% 111B
17.78x0.2x12.52x0.74% 62.18B
29.88x7.24x18.9x1.34% 48.4B
36.22x3.23x11.01x2.36% 45.83B
38.84x1.41x12.39x0.25% 34.26B
30.28x5.43x17.3x-.--% 28.88B
39.3x6.88x24.65x0.27% 23.72B
25.36x3.69x13.29x1.14% 22.45B
Average 29.78x 3.97x 15.38x 1.33% 56.38B
Weighted average by Cap. 28.11x 3.77x 14.89x 1.93%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. ABLD Stock
  4. Valuation ABL Diagnostics